{"hands_on_practices": [{"introduction": "A cornerstone of cell and developmental biology is the ability to distinguish different cell types based on their unique molecular signatures. This exercise focuses on the fundamental markers that define epithelial and mesenchymal cells. By considering a classic immunohistochemistry scenario, you will apply your knowledge of cytoskeletal protein expression to a practical problem in cell identification, a critical skill for interpreting tissue architecture during development and disease [@problem_id:1684933].", "problem": "A developmental biologist is investigating the process of gastrulation in a chick embryo, specifically focusing on the formation of the mesoderm. During this process, cells from the epiblast, an epithelial layer, undergo an Epithelial-Mesenchymal Transition (EMT). This transition allows them to lose their tight connections, delaminate from the epiblast, and migrate inwards through a structure called the primitive streak to form the mesenchymal mesoderm layer.\n\nThe researcher wants to use immunofluorescence to create an image that clearly distinguishes the stationary, pre-transitional epithelial cells of the epiblast from the migratory mesenchymal cells that have already passed through the primitive streak. They have two primary antibodies available for this purpose: one specifically targets cytokeratin proteins, and the other specifically targets vimentin proteins. Both cytokeratin and vimentin are types of intermediate filament proteins that form part of the cell's cytoskeleton.\n\nTo achieve the goal of specifically labeling the epithelial epiblast while leaving the newly formed mesenchymal cells unlabeled, which antibody should the researcher choose?\n\nA. The antibody against vimentin.\nB. The antibody against cytokeratin.\nC. Both antibodies would label the epithelial epiblast equally well.\nD. Neither antibody is suitable for distinguishing these two cell types.", "solution": "Step 1: Define the labeling goal precisely. The researcher wants to label stationary epithelial epiblast cells and avoid labeling migratory mesenchymal cells formed after passing through the primitive streak.\n\nStep 2: Recall the differential expression of intermediate filament proteins in epithelial versus mesenchymal cells. A core principle in cell biology is that epithelial cells characteristically express cytokeratins as their intermediate filaments, whereas mesenchymal cells characteristically express vimentin. This distinction is widely used as a diagnostic marker set for epithelial versus mesenchymal identity.\n\nStep 3: Apply the biological changes during EMT. During Epithelial-Mesenchymal Transition, epithelial cells downregulate epithelial markers (such as cytokeratins and E-cadherin) and upregulate mesenchymal markers (such as vimentin and N-cadherin). Therefore, post-EMT mesenchymal cells are expected to be vimentin-positive and cytokeratin-negative (or markedly reduced), while pre-EMT epithelial epiblast cells are cytokeratin-positive and vimentin-negative.\n\nStep 4: Match antibody choice to the labeling requirement. To specifically label epithelial epiblast cells and leave mesenchymal cells unlabeled, the antibody must detect a marker present in epithelium and absent in mesenchyme. The anti-cytokeratin antibody satisfies this criterion. In contrast, the anti-vimentin antibody would label the mesenchymal population rather than the epithelial epiblast. Consequently, both antibodies would not label the epiblast equally, and it is not true that neither can distinguish the two cell types.\n\nConclusion: The correct choice to label epithelial epiblast cells while leaving mesenchymal cells unlabeled is the antibody against cytokeratin.", "answer": "$$\\boxed{B}$$", "id": "1684933"}, {"introduction": "Beyond identifying cell states, understanding how cells communicate to induce phenotype changes is crucial. This practice moves from static markers to the dynamic process of intercellular signaling, specifically exploring how mesenchymal cells might induce EMT in their epithelial neighbors. You will interpret quantitative data from a Transwell assay, a standard cell biology technique, to dissect the role of soluble factors and exosomes in mediating this complex transition [@problem_id:1684911]. This exercise will sharpen your ability to analyze experimental results and formulate mechanistic conclusions.", "problem": "A developmental biologist is investigating the mechanisms behind Epithelial-Mesenchymal Transition (EMT), a process where epithelial cells lose their polarity and adhesion while gaining migratory and invasive properties. The researcher hypothesizes that mesenchymal cells can induce EMT in neighboring epithelial cells through the horizontal transfer of signaling molecules packaged within exosomes. To test this, an experiment is conducted using a human epithelial cell line (Epi) and a human mesenchymal cell line (Mesen). The experiment consists of four distinct culture conditions, and after 72 hours, the epithelial cells from each condition are analyzed. The expression levels of the epithelial marker E-cadherin (gene `CDH1`) and the mesenchymal marker Vimentin (gene `VIM`) are measured using Reverse Transcription-Quantitative Polymerase Chain Reaction (RT-qPCR).\n\nThe four experimental groups are:\n*   **Group 1:** Epi cells cultured alone in a standard culture dish. The expression levels in this group are set as the baseline (1.0-fold).\n*   **Group 2:** Epi cells cultured in the bottom chamber of a Transwell plate, with another population of Epi cells cultured in the porous insert above. The pores in the insert (0.4 Âµm) allow the passage of soluble molecules but prevent cell migration and direct contact.\n*   **Group 3:** Epi cells cultured in the bottom chamber of a Transwell plate, with Mesen cells cultured in the porous insert above.\n*   **Group 4:** Epi cells cultured alone in a standard culture dish, but their medium is supplemented with a high concentration of purified exosomes that were isolated from the culture medium of Mesen cells.\n\nThe RT-qPCR results, expressed as mean fold change in gene expression relative to Group 1, are summarized in the table below:\n\n| Group | Culture Condition                               | `CDH1` (Epithelial Marker) Fold Change | `VIM` (Mesenchymal Marker) Fold Change |\n|-------|-------------------------------------------------|----------------------------------------|----------------------------------------|\n| 1     | Epi cells alone                                 | 1.00                                   | 1.00                                   |\n| 2     | Epi cells (bottom) + Epi cells (insert)       | 1.05                                   | 0.98                                   |\n| 3     | Epi cells (bottom) + Mesen cells (insert)     | 0.18                                   | 5.21                                   |\n| 4     | Epi cells + Purified Mesenchymal Exosomes     | 0.22                                   | 4.95                                   |\n\nBased on the data provided, what is the most scientifically sound conclusion that can be drawn from this experiment?\n\nA. Direct cell-to-cell contact is the primary mechanism by which mesenchymal cells induce EMT in epithelial cells.\nB. High cell density is sufficient to trigger a spontaneous Epithelial-Mesenchymal Transition in the epithelial cell line used.\nC. Mesenchymal cells secrete soluble factors that induce molecular changes characteristic of EMT in epithelial cells, and these factors are predominantly carried within exosomes.\nD. Exosomes from mesenchymal cells are capable of initiating EMT, but non-exosomal soluble factors are clearly the principal drivers of this transition.\nE. Mesenchymal cells induce a generalized suppression of gene expression in epithelial cells, leading to a decrease in both epithelial and mesenchymal markers.", "solution": "We define a molecular EMT-like response in epithelial cells as a coordinated decrease in the epithelial marker `CDH1` (E-cadherin) and an increase in the mesenchymal marker `VIM` (Vimentin).\n\nInterpretation of controls:\n1) Group 1 (Epi alone) sets the baseline at 1.00 for both `CDH1` and `VIM`.\n2) Group 2 (Epi bottom + Epi insert; pores allow soluble factor exchange, no direct contact) yields `CDH1`=1.05 and `VIM`=0.98, both approximately equal to baseline. This indicates that neither high epithelial cell density nor epithelial-derived soluble factors produce EMT-like changes under these conditions. It also validates the Transwell system as not intrinsically altering these markers.\n\nTest of mesenchymal soluble signaling without direct contact:\n3) Group 3 (Epi bottom + Mesen insert; no direct contact) shows `CDH1`=0.18 and `VIM`=5.21, a strong EMT-like shift. Because the Transwell prevents direct cell-to-cell contact (with small-pore separation), the observed effects must be mediated by soluble factors released by mesenchymal cells. Therefore, direct contact is not required, and soluble mesenchymal signals are sufficient to induce EMT-like changes. This directly contradicts the claim that direct contact is the primary mechanism.\n\nTest of exosome sufficiency:\n4) Group 4 (Epi + purified mesenchymal exosomes) shows `CDH1`=0.22 and `VIM`=4.95, closely matching Group 3. This demonstrates that exosomes alone, isolated from mesenchymal secretions, are sufficient to recapitulate the EMT-like molecular changes observed with mesenchymal cells across a Transwell. The close quantitative similarity between Group 3 and Group 4 supports the interpretation that the key EMT-inducing signals are predominantly carried within exosomes, although it does not exclude minor contributions from non-exosomal soluble factors.\n\nEvaluation of options:\n- A is not supported because Group 3 shows robust EMT-like changes without direct contact.\n- B is contradicted by Group 2, which shows no EMT-like change despite increased cell density and soluble factor exchange between epithelial cells.\n- C is supported: mesenchymal cells release soluble factors that induce EMT-like changes, and the near-equivalence of Groups 3 and 4 indicates these factors are predominantly carried in exosomes.\n- D is not supported because exosome-only treatment (Group 4) nearly recapitulates the Transwell mesenchymal effect (Group 3), arguing against non-exosomal dominance.\n- E is contradicted because `VIM` increases strongly while `CDH1` decreases, indicating a specific EMT program rather than generalized suppression.\n\nTherefore, the most scientifically sound conclusion is that mesenchymal cells secrete soluble factors that induce EMT-like molecular changes in epithelial cells, and these factors are predominantly carried within exosomes.", "answer": "$$\\boxed{C}$$", "id": "1684911"}, {"introduction": "The switch-like, often irreversible, nature of EMT suggests the involvement of robust underlying regulatory mechanisms. This advanced problem transitions from experimental observation to theoretical modeling to explain this cellular behavior. By deriving and analyzing a system of ordinary differential equations for the core ZEB/miR-200 mutual inhibition loop, you will explore how this network architecture can generate bistability, a property allowing cells to exist in one of two distinct, stable states [@problem_id:2635499]. This practice develops skills in mathematical modeling and stability analysis, providing a powerful quantitative framework for understanding cellular decision-making.", "problem": "Epithelial-mesenchymal transition (EMT) is regulated in part by a mutual inhibition loop between the microRNA-200 family (miR-200) and the Zinc finger E-box binding homeobox (ZEB) transcription factors, which promotes mutually exclusive epithelial versus mesenchymal states. From the Central Dogma of molecular biology (DNA transcribed to RNA and translated to protein) and standard gene-regulatory phenomenology, model each molecular speciesâ temporal dynamics as a balance between synthesis and first-order degradation. For transcriptional or post-transcriptional repression, assume a Hill-type input-output relationship reflecting cooperative binding. \n\n1) Using these foundations, derive a minimal two-variable ordinary differential equation model for the concentrations $M(t)$ (miR-200) and $Z(t)$ (ZEB) in which:\n- miR-200 synthesis is repressed by ZEB,\n- ZEB synthesis is repressed by miR-200,\n- each species is removed by first-order degradation.\nWrite the general form of the model with maximal synthesis rates $\\alpha_{M}$ and $\\alpha_{Z}$, Hill coefficients $n_{ZM}$ and $n_{MZ}$, dissociation constants $K_{ZM}$ and $K_{MZ}$, and degradation rate constants $\\delta_{M}$ and $\\delta_{Z}$.\n\n2) Specialize to the symmetric case $\\alpha_{M}=\\alpha_{Z}=\\alpha$, $\\delta_{M}=\\delta_{Z}=\\delta$, $K_{ZM}=K_{MZ}=K$, and $n_{ZM}=n_{MZ}=n$, with $n>1$ capturing cooperativity. Perform a steady-state analysis to:\n- Show that a symmetric steady state $M^{\\ast}=Z^{\\ast}=m$ satisfies a scalar algebraic condition that you must derive.\n- Linearize the system about the symmetric steady state, obtain the Jacobian matrix, and determine the condition on parameters at which the symmetric steady state changes stability.\n\n3) Use your analysis to identify the onset of bistability as the parameter $\\alpha$ is increased (for fixed $\\delta$, $K$, and $n>1$). Derive a closed-form analytic expression for the critical production rate value $\\alpha_{c}$ at which bistability appears. Express your final answer as a single analytical expression in terms of $\\delta$, $K$, and $n$. Do not include units in your final answer. If you choose to provide a numerical check, it will not be graded; only the exact analytic expression is required.", "solution": "The problem requires the derivation and analysis of a mathematical model for the epithelial-mesenchymal transition (EMT) regulatory network. The process will be conducted in three parts as specified: model derivation, steady-state analysis of the symmetric case, and calculation of the critical parameter for the onset of bistability.\n\n**Part 1: Derivation of the minimal two-variable ODE model**\n\nThe temporal dynamics of the concentrations of miR-200, denoted by $M(t)$, and ZEB, denoted by $Z(t)$, are governed by the balance of their synthesis and degradation rates.\n\nThe degradation of each species is assumed to be a first-order process. Thus, the degradation rate for $M$ is $\\delta_M M$ and for $Z$ is $\\delta_Z Z$, where $\\delta_M$ and $\\delta_Z$ are the respective first-order degradation rate constants.\n\nThe synthesis of each species is regulated by mutual repression. We use a decreasing Hill function to model this repression, reflecting cooperative binding of the repressor.\nThe synthesis of miR-200 is repressed by ZEB. The rate of synthesis of $M$ is given by a Hill-type function of $Z$:\n$$ \\text{Synthesis of } M = \\alpha_M \\frac{K_{ZM}^{n_{ZM}}}{K_{ZM}^{n_{ZM}} + Z^{n_{ZM}}} $$\nHere, $\\alpha_M$ is the maximal synthesis rate of miR-200, $K_{ZM}$ is the dissociation constant (the concentration of ZEB at which the repression is half-maximal), and $n_{ZM}$ is the Hill coefficient, which quantifies the cooperativity of repression by ZEB on the miR-200 promoter.\n\nSimilarly, the synthesis of ZEB is repressed by miR-200. The rate of synthesis of $Z$ is:\n$$ \\text{Synthesis of } Z = \\alpha_Z \\frac{K_{MZ}^{n_{MZ}}}{K_{MZ}^{n_{MZ}} + M^{n_{MZ}}} $$\nwhere $\\alpha_Z$, $K_{MZ}$, and $n_{MZ}$ are the corresponding parameters for the repression of ZEB by miR-200.\n\nCombining the synthesis and degradation terms, the system of ordinary differential equations (ODEs) describing the dynamics of $M(t)$ and $Z(t)$ is:\n$$ \\frac{dM}{dt} = \\alpha_M \\frac{K_{ZM}^{n_{ZM}}}{K_{ZM}^{n_{ZM}} + Z^{n_{ZM}}} - \\delta_M M $$\n$$ \\frac{dZ}{dt} = \\alpha_Z \\frac{K_{MZ}^{n_{MZ}}}{K_{MZ}^{n_{MZ}} + M^{n_{MZ}}} - \\delta_Z Z $$\nThis is the general form of the minimal two-variable model as requested.\n\n**Part 2: Steady-state analysis of the symmetric case**\n\nWe consider the symmetric case where the parameters are identical for both species: $\\alpha_M = \\alpha_Z = \\alpha$, $\\delta_M = \\delta_Z = \\delta$, $K_{ZM} = K_{MZ} = K$, and $n_{ZM} = n_{MZ} = n$, with $n>1$. The system of ODEs simplifies to:\n$$ \\frac{dM}{dt} = \\alpha \\frac{K^n}{K^n + Z^n} - \\delta M $$\n$$ \\frac{dZ}{dt} = \\alpha \\frac{K^n}{K^n + M^n} - \\delta Z $$\n\nA steady state $(M^*, Z^*)$ is a point where the rates of change are zero, i.e., $\\frac{dM}{dt} = 0$ and $\\frac{dZ}{dt} = 0$.\nA symmetric steady state is one where $M^* = Z^* = m$. Substituting this into either of the steady-state equations yields a scalar algebraic condition for $m$:\n$$ \\alpha \\frac{K^n}{K^n + m^n} - \\delta m = 0 $$\nThis can be rewritten as:\n$$ \\alpha K^n = \\delta m (K^n + m^n) $$\nThis is the required scalar algebraic condition for the symmetric steady state concentration $m$.\n\nTo analyze the stability of this steady state, we linearize the system around the point $(m,m)$. The Jacobian matrix $J$ of the system is given by:\n$$ J(M,Z) = \\begin{pmatrix} \\frac{\\partial}{\\partial M}(\\dot{M}) & \\frac{\\partial}{\\partial Z}(\\dot{M}) \\\\ \\frac{\\partial}{\\partial M}(\\dot{Z}) & \\frac{\\partial}{\\partial Z}(\\dot{Z}) \\end{pmatrix} $$\nThe partial derivatives are:\n$$ \\frac{\\partial \\dot{M}}{\\partial M} = -\\delta $$\n$$ \\frac{\\partial \\dot{M}}{\\partial Z} = \\alpha K^n \\frac{-n Z^{n-1}}{(K^n + Z^n)^2} $$\n$$ \\frac{\\partial \\dot{Z}}{\\partial M} = \\alpha K^n \\frac{-n M^{n-1}}{(K^n + M^n)^2} $$\n$$ \\frac{\\partial \\dot{Z}}{\\partial Z} = -\\delta $$\nEvaluating the Jacobian at the symmetric steady state $(m,m)$:\n$$ J(m,m) = \\begin{pmatrix} -\\delta & -\\frac{\\alpha n K^n m^{n-1}}{(K^n + m^n)^2} \\\\ -\\frac{\\alpha n K^n m^{n-1}}{(K^n + m^n)^2} & -\\delta \\end{pmatrix} $$\nThe stability of the steady state is determined by the eigenvalues $\\lambda$ of this matrix, which are the roots of the characteristic equation $\\det(J - \\lambda I) = 0$:\n$$ (-\\delta - \\lambda)^2 - \\left( -\\frac{\\alpha n K^n m^{n-1}}{(K^n + m^n)^2} \\right)^2 = 0 $$\nLet $C = \\frac{\\alpha n K^n m^{n-1}}{(K^n + m^n)^2}$. The equation is $(\\lambda + \\delta)^2 - C^2 = 0$, which gives $\\lambda + \\delta = \\pm C$.\nThe eigenvalues are $\\lambda_1 = -\\delta - C$ and $\\lambda_2 = -\\delta + C$. Since all parameters and concentrations are positive, $C > 0$.\nThe eigenvalue $\\lambda_1$ is always negative. The stability of the symmetric steady state is therefore determined by the sign of $\\lambda_2$. The state is stable if $\\lambda_2 < 0$, i.e., $C < \\delta$. It loses stability when $\\lambda_2$ becomes positive, i.e., $C > \\delta$.\nThe change in stability occurs at a bifurcation point where $\\lambda_2 = 0$. The condition for this is $C = \\delta$:\n$$ \\frac{\\alpha n K^n m^{n-1}}{(K^n + m^n)^2} = \\delta $$\nThis is the condition on the parameters at which the symmetric steady state changes stability.\n\n**Part 3: Derivation of the critical production rate $\\alpha_c$**\n\nThe onset of bistability in this system corresponds to a pitchfork bifurcation, where the symmetric steady state becomes unstable and gives rise to two new, stable, asymmetric steady states. This event occurs at the critical value of the production rate, $\\alpha_c$, where the stability condition derived above is met. To find $\\alpha_c$, we must simultaneously solve the two conditions for the bifurcation point $(m_c, \\alpha_c)$:\n\n1.  The steady-state condition: $\\alpha_c = \\frac{\\delta m_c (K^n + m_c^n)}{K^n}$\n2.  The stability change condition: $\\frac{\\alpha_c n K^n m_c^{n-1}}{(K^n + m_c^n)^2} = \\delta$\n\nWe can solve this system. First, substitute the expression for $\\alpha_c$ from equation (1) into equation (2):\n$$ \\frac{\\left( \\frac{\\delta m_c (K^n + m_c^n)}{K^n} \\right) n K^n m_c^{n-1}}{(K^n + m_c^n)^2} = \\delta $$\nAssuming $\\delta \\neq 0$, we can simplify this expression:\n$$ \\frac{\\delta n m_c^n (K^n + m_c^n)}{(K^n + m_c^n)^2} = \\delta $$\n$$ \\frac{n m_c^n}{K^n + m_c^n} = 1 $$\nThis gives a condition for the concentration $m_c$ at the bifurcation:\n$$ n m_c^n = K^n + m_c^n $$\n$$ (n-1) m_c^n = K^n $$\nSince $n > 1$, we can solve for $m_c$:\n$$ m_c^n = \\frac{K^n}{n-1} \\implies m_c = K \\left( \\frac{1}{n-1} \\right)^{1/n} $$\n\nNow, we substitute this value of $m_c$ back into the steady-state equation (1) to find the critical production rate $\\alpha_c$.\nFirst, substitute the expression for $m_c^n$:\n$$ \\alpha_c = \\frac{\\delta m_c (K^n + \\frac{K^n}{n-1})}{K^n} = \\delta m_c \\left( 1 + \\frac{1}{n-1} \\right) = \\delta m_c \\left( \\frac{n-1+1}{n-1} \\right) = \\delta m_c \\frac{n}{n-1} $$\nFinally, substitute the expression for $m_c$:\n$$ \\alpha_c = \\delta \\left( K \\left( \\frac{1}{n-1} \\right)^{1/n} \\right) \\frac{n}{n-1} $$\n$$ \\alpha_c = \\delta K \\frac{n}{n-1} (n-1)^{-1/n} = \\delta K \\frac{n}{(n-1)^{1 + 1/n}} $$\nThis can be written as:\n$$ \\alpha_c = \\delta K \\frac{n}{(n-1)^{\\frac{n+1}{n}}} $$\nThis is the closed-form analytic expression for the critical production rate at which bistability appears.", "answer": "$$\\boxed{\\delta K \\frac{n}{(n-1)^{\\frac{n+1}{n}}}}$$", "id": "2635499"}]}